WCN 2026 28 - 31 March 2026

Effect of once-weekly semaglutide 1.0 mg on kidney outcomes by baseline characteristics: Exploratory data from the FLOW trial

Authors :

Srikanth Bellary¹; Richard E. Pratley²; Katherine R. Tuttle^3,⁴; Peter Rossing^5,⁶; Kenneth W. Mahaffey⁷; Prachi Priyadarshini⁸; Christine Sofie Fuchs Jacobsen⁹; Poornima K.N.⁸; Johannes F.E. Mann^10,¹¹

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

Chronic Kidney Disease

Congress poster

GLP-1 RA

Semaglutide

PHASE 3 (RCT)

Search Science Hub

Are you a healthcare professional?

Effect of once-weekly semaglutide 1.0 mg on kidney outcomes by baseline characteristics: Exploratory data from the FLOW trial